$MYGN
MYRIAD GENETICS INC

2013 Q4 Form 10-Q Financial Statement

#000119312514036458 Filed on February 05, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2012 Q4
Revenue $204.1M $149.1M
YoY Change 36.82% 21.44%
Cost Of Revenue $22.76M $15.57M
YoY Change 46.18% 21.47%
Gross Profit $181.3M $133.6M
YoY Change 35.73% 21.44%
Gross Profit Margin 88.85% 89.56%
Selling, General & Admin $77.84M $59.56M
YoY Change 30.69% 16.82%
% of Gross Profit 42.93% 44.59%
Research & Development $17.09M $14.11M
YoY Change 21.15% 37.72%
% of Gross Profit 9.43% 10.56%
Depreciation & Amortization $2.400M $2.300M
YoY Change 4.35% 0.0%
% of Gross Profit 1.32% 1.72%
Operating Expenses $94.93M $73.67M
YoY Change 28.86% 20.32%
Operating Profit $83.00M $55.59M
YoY Change 49.32% 22.26%
Interest Expense $1.300M $1.400M
YoY Change -7.14% 0.0%
% of Operating Profit 1.57% 2.52%
Other Income/Expense, Net $1.145M $1.399M
YoY Change -18.16% -1499.0%
Pretax Income $84.14M $56.99M
YoY Change 47.66% 21.81%
Income Tax $33.78M $21.95M
% Of Pretax Income 40.15% 38.52%
Net Earnings $50.36M $35.04M
YoY Change 43.74% 23.82%
Net Earnings / Revenue 24.68% 23.49%
Basic Earnings Per Share $0.67 $0.43
Diluted Earnings Per Share $0.66 $0.42
COMMON SHARES
Basic Shares Outstanding 75.07M shares 81.69M shares
Diluted Shares Outstanding 76.83M shares 84.24M shares

Balance Sheet

Concept 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $353.6M $358.6M
YoY Change -1.39% 2.28%
Cash & Equivalents $71.60M $68.42M
Short-Term Investments $282.0M $290.2M
Other Short-Term Assets $13.30M $11.70M
YoY Change 13.68% -57.45%
Inventory $10.47M
Prepaid Expenses $4.237M $2.327M
Receivables $84.14M $75.56M
Other Receivables $3.500M $1.000M
Total Short-Term Assets $454.5M $457.3M
YoY Change -0.62% 5.77%
LONG-TERM ASSETS
Property, Plant & Equipment $31.31M $27.29M
YoY Change 14.76% 12.28%
Goodwill $56.85M $56.85M
YoY Change 0.0%
Intangibles $12.84M $13.72M
YoY Change -6.39%
Long-Term Investments $135.2M $109.6M
YoY Change 23.36% 41.24%
Other Assets $43.00M $32.60M
YoY Change 31.9% -9.7%
Total Long-Term Assets $302.2M $260.4M
YoY Change 16.04% 13.77%
TOTAL ASSETS
Total Short-Term Assets $454.5M $457.3M
Total Long-Term Assets $302.2M $260.4M
Total Assets $756.7M $717.7M
YoY Change 5.42% 8.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.60M $13.58M
YoY Change 29.62% 52.53%
Accrued Expenses $45.84M $29.19M
YoY Change 57.04% 23.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $67.39M $45.49M
YoY Change 48.15% 29.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.30M $10.10M
YoY Change 31.68% 7.45%
Total Long-Term Liabilities $13.30M $10.10M
YoY Change 31.68% 7.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $67.39M $45.49M
Total Long-Term Liabilities $13.30M $10.10M
Total Liabilities $80.71M $55.63M
YoY Change 45.09% 25.0%
SHAREHOLDERS EQUITY
Retained Earnings $11.60M -$4.272M
YoY Change -371.61%
Common Stock $740.0K $813.0K
YoY Change -8.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $676.0M $662.1M
YoY Change
Total Liabilities & Shareholders Equity $756.7M $717.7M
YoY Change 5.42% 8.54%

Cashflow Statement

Concept 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income $50.36M $35.04M
YoY Change 43.74% 23.82%
Depreciation, Depletion And Amortization $2.400M $2.300M
YoY Change 4.35% 0.0%
Cash From Operating Activities $47.50M $22.10M
YoY Change 114.93% -19.64%
INVESTING ACTIVITIES
Capital Expenditures -$2.800M -$4.500M
YoY Change -37.78% 15.38%
Acquisitions
YoY Change
Other Investing Activities $13.60M -$29.50M
YoY Change -146.1% -251.28%
Cash From Investing Activities $10.80M -$34.00M
YoY Change -131.76% -317.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -71.70M -15.30M
YoY Change 368.63% -610.0%
NET CHANGE
Cash From Operating Activities 47.50M 22.10M
Cash From Investing Activities 10.80M -34.00M
Cash From Financing Activities -71.70M -15.30M
Net Change In Cash -13.40M -27.20M
YoY Change -50.74% -159.0%
FREE CASH FLOW
Cash From Operating Activities $47.50M $22.10M
Capital Expenditures -$2.800M -$4.500M
Free Cash Flow $50.30M $26.60M
YoY Change 89.1% -15.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
72974449 shares
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86352000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80577000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.75
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14434970 shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80577000 shares
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
64509000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-424000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10718000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
56595000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
697346000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
18132000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
728594000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30866000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2043000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44334000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7500000
CY2013Q2 us-gaap Liabilities
Liabilities
75227000
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3620000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
806000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
803821000
CY2013Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
158748000
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5963000
CY2013Q2 us-gaap Goodwill
Goodwill
56850000
CY2013Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
18294000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13330000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94333000
CY2013Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84197000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8007000
CY2013Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
65903000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27602000
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
28632000
CY2013Q2 us-gaap Assets
Assets
803821000
CY2013Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
490652000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104073000
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8530000
CY2013Q2 us-gaap Other Assets
OtherAssets
13000000
CY2013Q2 us-gaap Notes Receivable Net
NotesReceivableNet
21667000
CY2013Q2 us-gaap Other Receivables
OtherReceivables
3373000
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.75
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17073928 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
9218423 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
21.39
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12150000
CY2013Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
16950000
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
268243000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
483992000
CY2013Q2 mygn Indefinite Lived Intangible Assets Gross Excluding Goodwill
IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
4800000
CY2011Q3 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
25000000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68423000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73974000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73974000 shares
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
67392000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
506000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13318000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60647000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
663122000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17596000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
675971000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11603000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3952000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45844000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9200000
CY2013Q4 us-gaap Liabilities
Liabilities
80710000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4108000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
740000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
756681000
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
135187000
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4237000
CY2013Q4 us-gaap Goodwill
Goodwill
56850000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
281882000
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
18390000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12842000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
84137000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
135187000
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
91960000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9074000
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
73570000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31313000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
29983000
CY2013Q4 us-gaap Assets
Assets
756681000
CY2013Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
434858000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71599000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8042000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
CY2013Q4 us-gaap Other Assets
OtherAssets
13000000
CY2013Q4 us-gaap Notes Receivable Net
NotesReceivableNet
23000000
CY2013Q4 us-gaap Other Receivables
OtherReceivables
3463000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
52276000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
135011000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12150000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
281996000
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
16950000
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
281996000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
488782000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
488492000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
454506000
CY2013Q4 mygn Residual Value Of Loan Agreement
ResidualValueOfLoanAgreement
17000000
CY2013Q4 mygn Fair Value Option Loans Aggregate Principal Amount Outstanding
FairValueOptionLoansAggregatePrincipalAmountOutstanding
8000000
CY2013Q4 mygn Indefinite Lived Intangible Assets Gross Excluding Goodwill
IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
4800000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84091000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2459000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39 pure
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3067000 shares
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
130000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73470000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4585000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81632000 shares
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7008000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2753000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1672000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
239264000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5899000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-114000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3623000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
267919000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1333000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
106807000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-72000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29851000
us-gaap Revenues
Revenues
282577000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65113000
us-gaap Operating Income Loss
OperatingIncomeLoss
104168000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
14658000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-501000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
79883000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2639000
us-gaap Net Income Loss
NetIncomeLoss
65172000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1490000
us-gaap Costs And Expenses
CostsAndExpenses
178409000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-52357000
us-gaap Share Based Compensation
ShareBasedCompensation
13704000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14729000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4455000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17929000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115691000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41635000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
667000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3580000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3434000
us-gaap Cost Of Revenue
CostOfRevenue
29498000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3623000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
506000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
207230000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39042000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25507000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
7713000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
23903000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
23122000
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
56760000
dei Trading Symbol
TradingSymbol
MYGN
dei Entity Registrant Name
EntityRegistrantName
MYRIAD GENETICS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000899923
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(1)</td> <td align="left" valign="top"><u>Basis of Presentation</u></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"> The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the &#x201C;Company&#x201D;) in accordance with U.S. generally accepted accounting principles (&#x201C;GAAP&#x201D;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto for the fiscal year ended June&#xA0;30, 2013, included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended June&#xA0;30, 2013. Operating results for the three and six months ended December&#xA0;31, 2013 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"> Certain reclassifications have been made to prior period amounts to conform to the current period presentation.</p> </div>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3304553 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79312000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1989000 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.48
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.37 pure
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
6991000 shares
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2600000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
138031000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
310866 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
24.33
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7136000 shares
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M26D
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77323000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.23
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
354729 shares
us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.07 pure
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8098000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
538000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2691000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
172000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
102661000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1826000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-623000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
592000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
389144000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1333000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1909000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1510000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-536000
us-gaap Cost Of Revenue
CostOfRevenue
44194000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
592000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
488000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
167971000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
392000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11597000
us-gaap Revenues
Revenues
406527000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
106755000
us-gaap Operating Income Loss
OperatingIncomeLoss
165903000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
17383000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1807000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-40000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
180124000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2068000
us-gaap Net Income Loss
NetIncomeLoss
105825000
us-gaap Costs And Expenses
CostsAndExpenses
240624000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-173170000
us-gaap Share Based Compensation
ShareBasedCompensation
13792000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21793000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4811000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-32474000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
155119000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62146000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
113424000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2665000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33893000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
7418000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6362000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
55036000
mygn Income Related To Accretion Of Note Receivable And Stated Interest Rate
IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate
2208000
CY2012Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-70000
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
125088000
CY2011Q3 mygn Effective Period Of Option
EffectivePeriodOfOption
3 Y
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84240000 shares
CY2012Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2548000 shares
CY2012Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39 pure
CY2012Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1231000 shares
CY2012Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5605000 shares
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81692000 shares
CY2012Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1385000
CY2012Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000
CY2012Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
140651000
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
56985000
CY2012Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000
CY2012Q4 us-gaap Revenues
Revenues
149140000
CY2012Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34686000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
55586000
CY2012Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
8489000
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1399000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
35036000
CY2012Q4 us-gaap Costs And Expenses
CostsAndExpenses
93554000
CY2012Q4 us-gaap Share Based Compensation
ShareBasedCompensation
7105000
CY2012Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2211000
CY2012Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59563000
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21949000
CY2012Q4 us-gaap Cost Of Revenue
CostOfRevenue
15566000
CY2012Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
231000
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14107000
CY2012Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4318000
CY2012Q4 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
9372000
CY2012Q4 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
24311000
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76825000 shares
CY2013Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1755000 shares
CY2013Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.40 pure
CY2013Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3185000 shares
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8500000 shares
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75070000 shares
CY2013Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
253000
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1330000
CY2013Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-185000
CY2013Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
196158000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
84144000
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-112000
CY2013Q4 us-gaap Revenues
Revenues
204060000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50501000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
82999000
CY2013Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
7902000
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1145000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
50360000
CY2013Q4 us-gaap Costs And Expenses
CostsAndExpenses
121061000
CY2013Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6857000
CY2013Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2438000
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77840000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33784000
CY2013Q4 us-gaap Cost Of Revenue
CostOfRevenue
22755000
CY2013Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
244000
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17090000
CY2013Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3376000
CY2013Q4 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
25096000
CY2013Q4 mygn Income Related To Accretion Of Note Receivable And Stated Interest Rate
IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate
1104000
CY2013Q4 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
52713000

Files In Submission

Name View Source Status
0001193125-14-036458-index-headers.html Edgar Link pending
0001193125-14-036458-index.html Edgar Link pending
0001193125-14-036458.txt Edgar Link pending
0001193125-14-036458-xbrl.zip Edgar Link pending
d630893d10q.htm Edgar Link pending
d630893dex311.htm Edgar Link pending
d630893dex312.htm Edgar Link pending
d630893dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mygn-20131231.xml Edgar Link completed
mygn-20131231.xsd Edgar Link pending
mygn-20131231_cal.xml Edgar Link unprocessable
mygn-20131231_def.xml Edgar Link unprocessable
mygn-20131231_lab.xml Edgar Link unprocessable
mygn-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending